A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Roswell Park Cancer Institute
Ohio State University Comprehensive Cancer Center
University of Nebraska
Thomas Jefferson University
M.D. Anderson Cancer Center
Massachusetts General Hospital
M.D. Anderson Cancer Center
Mayo Clinic
Mayo Clinic
M.D. Anderson Cancer Center
Acerta Pharma BV
H. Lee Moffitt Cancer Center and Research Institute
Thomas Jefferson University
Case Comprehensive Cancer Center
Thomas Jefferson University
Thomas Jefferson University
Bristol-Myers Squibb
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Colorado, Denver
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Columbia University
Fred Hutchinson Cancer Center
Thomas Jefferson University
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
Thomas Jefferson University
Thomas Jefferson University
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center
Advice Pharma Group srl
Mundipharma Research Limited
Pfizer
City of Hope Medical Center
OHSU Knight Cancer Institute
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Beth Israel Deaconess Medical Center
Washington University School of Medicine
University of Nebraska
University of Nebraska
University of Birmingham
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Northside Hospital, Inc.
University Hospital, Clermont-Ferrand